Chromosome damage and repair in children with sickle cell anaemia and long-term hydroxycarbamide exposure
about
Update on the use of hydroxyurea therapy in sickle cell diseaseHydroxyurea for sickle cell anemia: what have we learned and what questions still remain?Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia.Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: results from the BABY-HUG Phase III Clinical Trial.Hydroxyurea for the treatment of sickle cell disease: efficacy, barriers, toxicity, and management in children.Prospects for primary stroke prevention in children with sickle cell anaemiaFrom infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemia.Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemiaUtility of hydroxyurea in mast cell activation syndrome.Hydroxyurea (hydroxycarbamide) for sickle cell disease.Risk factors for non-melanoma skin cancer in patients with essential thrombocythemia and polycythemia vera.A predictable but life-threatening complication of hydroxyurea in a patient with sickle cell anaemia: an experience learned from a Jehovah's Witness.Clinical Course of Two Children with Unstable Hemoglobins: The Effect of Hydroxyurea Therapy.The effect of hydroxcarbamide therapy on survival of children with sickle cell disease.
P2860
Q34737460-8AA15E13-7C07-4B13-B86C-C0A2E7075BABQ35234959-2F467E63-6D7E-48A1-A7BD-D138E8C99286Q35525659-A8EAFCB3-B7E7-4628-B7CA-C3ADF163241FQ35751797-9F22EB6B-8512-4005-90FF-DFA898EBFF45Q36028317-127E69D3-5084-41B2-BE1C-267EDE0DDF5FQ36105129-1BD8B474-35D8-4E98-A684-6FD5F4A56BA5Q36154109-21389718-DB53-4D82-A383-B5F0D5D19CC0Q36966277-CBE7D638-E940-4A31-85CC-433AB2F51E4EQ37365376-46A5D89A-CF2D-4D3F-8AA3-CE69CA3665FBQ38692796-F65216DD-B48D-4234-B58C-B6F61EDA954CQ40916710-31B1A082-BD58-46F9-B48C-82A942760B18Q41659212-D7637644-5014-406F-9368-8D2DEB501827Q47673727-E9816126-5D3F-409F-8B67-FB7CB4F69978Q51065755-7EF83E6D-1C30-4DAB-B38C-36F6806AF2E4
P2860
Chromosome damage and repair in children with sickle cell anaemia and long-term hydroxycarbamide exposure
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Chromosome damage and repair i ...... term hydroxycarbamide exposure
@ast
Chromosome damage and repair i ...... term hydroxycarbamide exposure
@en
type
label
Chromosome damage and repair i ...... term hydroxycarbamide exposure
@ast
Chromosome damage and repair i ...... term hydroxycarbamide exposure
@en
prefLabel
Chromosome damage and repair i ...... term hydroxycarbamide exposure
@ast
Chromosome damage and repair i ...... term hydroxycarbamide exposure
@en
P2093
P2860
P1476
Chromosome damage and repair i ...... term hydroxycarbamide exposure
@en
P2093
Jill M Lahti
Jonathan M Flanagan
Patrick T McGann
Russell E Ware
Thad A Howard
P2860
P304
P356
10.1111/J.1365-2141.2011.08698.X
P407
P577
2011-05-04T00:00:00Z